A sensitive method for quantifying cytomegalic endothelial cells in peripheral blood from cytomegalovirus-infected patients

Clinical and Diagnostic Laboratory Immunology

Volumn 5, Issue 5, 1998, Pages 622-626

  Kas Deelen, A M ^a   Harmsen, M C ^a   De Maar, E F ^a   Van Son, W J ^a   The, T H ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY SPECIFICITY; ARTICLE; BLOOD SAMPLING; CELL ISOLATION; CYTOMEGALOVIRUS INFECTION; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; FLUORESCENCE ACTIVATED CELL SORTER; HUMAN; HUMAN CELL; HUMAN TISSUE; NORMAL HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS;

EID: 0032406158     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.5.5.622-626.1998     Document Type: Article

References (31)

1. Almeida, G. D., C. D. Porada, S. S. St. Jeor, and J. L. Ascensao. 1994. Human cytomegalovirus alters interleukin-6 production by endothelial cells. Blood 83:370-376.
2. Bruggeman, C. A., W. H. M. Debie, A. D. Muller, B. Schutte, and M. C. E. van Dam-Mieras. 1988. Cytomegalovirus alters the von Willebrand factor content in human endothelial cells. Thromb. Haemostasis 58:264-268.
3. de Maar, E. F., J. H. Kleibeuker, W. Boersma-van Ek, T. H. The, and W. J. van Son. 1996. Increased intestinal permeability during cytomegalovirus infections in renal transplant recipients. Transplant. Int. 9:576-580.
4. Einsele, H., G. Ehninger, M. Steidle, I. Fischer, S. Bihler, F. Gerneth, A. Vallbracht, H. Schmidt, H. D. Waller, and C. A. Muller. 1993. Lymphocytopenia as an infavorable prognostic factor in patients with cytomegalovirus infection after bone marrow transplantation. Blood 82:1672-1678.
5. Garrett, J. S., J. C. Narus, J. F. Bohnsack, D. E. Carling, K. G. Grieves, W. J. Waldman, and R. E. Shaddy. 1995. Effects of cytomegalovirus infection on growth factor production in endothelial cells and fibroblasts. Pediatr. Res. 38:1003-1008.
6. George, F., C. Brisson, P. Poncelet, J. C. Laurent, O. Massot, D. Arnoux, P. Ambrosi, C. Klein-Soyer, and J. P. Cavenaze. 1992. Rapid isolation of human endothelial cells from whole blood using S-Endo1 monoclonal antibody coupled to immuno-magnetic heads: demonstration of endothelial injury after angioplasty. Thromb. Haemostasis 67:147-153.
7. George, F., P. Brouqui, M. C. Boffa, and M. Mutin. 1993. Demonstration of Rickettsia Conorii-induced endothelial injury in vivo by measuring circulating endothelial cells, thrombomodulin, and von Willebrand factor in patients with Mediterranean Spotted Fever. Blood 82:2109-2116.
8. Gerna, G., E. Percivalle, M. G. Revello, and F. Morini. 1993. Correlation of quantitative human cytomegalovirus pp65-, p72- and p150-antigenemia, viremia and circulating endothelial giant cells with clinical symptoms and antiviral treatment in immunocompromised patients. Clin. Diagn. Virol. 1:47-59.
9. Grefte, A., M. van der Giessen, W. J. van Son, and T. H. The. 1993. Circulating cytomegalovirus (CMV)-infected endothelial cells in patients with an active CMV infection. J. Infect. Dis. 167:270-277.
10. Grefte, A., N. Blom, M. van der Giessen, W. J. van Son, and T. H. The. 1993. Ultrastructural analysis of circulating cytomegalic cells in patients with active cytomegalovirus infection: evidence for virus production and endothelial origin. J. Infect. Dis. 168:1110-1118.
11. Grefte, J. M. M., B. T. F. van der Gun, S. Schmolke, M. van der Giessen, W. J. van Son, B. Plachter, G. Jahn, and T. H. The. 1992. The lower matrix protein pp65 is the principal viral antigen present in peripheral blood leukocytes during an active cytomegalovirus infection. J. Gen. Virol. 73:923-932.
12. -7. Proc. Natl. Acad. Sci. USA 92:537-541.
13. Jaffe, E. A., R. L. Nachman, C. G. Becher, and C. R. Minick. 1973. Culture of human endothelial cells derived from umbilical veins: identification by morphologic and immunologic criteria. J. Clin. Investig. 52:2745-2756.
14. Lefevre, P., F. George, J. M. Durand, and J. Sampol. 1993. Detection of circulating endothelial cells in thrombotic thrombocytopenic purpura. Thromb. Haemostasis 69:522-532.
15. Mazeron, M. C., G. Jahn, and B. Plachter. 1992. Monoclonal antibody E-13 (M-810) to human cytomegalovirus recognizes an epitope encoded by exon 2 of the major immediate early gene. J. Gen. Virol. 73:2699-2703.
16. Mulder, A. B., N. R. Blom, M. H. J. Ruiters, J. van der Meer, M. R. Halie, and V. J. J. Bom. 1995. Basal tissue factor expression in endothelial cell cultures is caused by contaminating smooth muscle cells: reduction by using chymotrypsin instead of collagenase. Thromb. Res. 80:399-411.
17. Percivalle, E., M. G. Revello, L. Vago, and G. Gerna. 1993. Circulating endothelial giant cells permissive for human cytomegalovirus (CMV) are detected in disseminated CMV infections with organ involvement. J. Clin. Investig. 92:663-670.
18. Pober, J. S., M. A. Gimbrone, Jr., L. A. Lapiere, D. L. Mendrick, W. Fiers, R. Rothlein, and T. A. Springer. 1986. Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. J. Immunol. 137:1893-1896.
19. Radbruch, A., and D. Recktenwald. 1995. Detection and isolation of rare cells. Curr. Opin. Immunol. 7:270-273.
20. Sbarbati, R., M. de Boer, and M. Marzilli. 1991. Immunologic detection of endothelial cells in human whole blood. Blood 77:764-769.
21. Sedmak, D. D., D. A. Knight, N. C. Vook, and W. J. Waldman. 1994. Divergent patterns of ELAM-1, ICAM-1, and VCAM-1 expression on cytomegalovirus-infected endothelial cells. Transplantation 58:1379-1385.
22. Shahgasempour, S., S. B. Woodroffe, G. Sullivan-Tailyour, and H. M. Garnett. 1997. Alterations in the expression of endothelial cell integrin receptors α5β1 and α2β1 and α6β1 after in vitro infection with a clinical isolate of human cytomegalovirus. Arch. Virol. 142:125-138.
23. Sinzger, C., A. Grefte, B. Plachter, A. S. H. Gouw, T. H. The, and G. Jahn. 1995. Fibroblasts, epithelial cells, endothelial cells and smooth muscle cells are major targets of human cytomegalovirus infection in lung and gastrointestinal tissues. J. Gen. Virol. 76:741-750.
24. Sinzger, C., J. Knapp, B. Plachter, K. Schmidt, and G. Jahn. 1997. Quantification of replication of clinical cytomegalovirus isolates in cultured endothelial cells and fibroblasts by a focus expansion assay. J. Virol. Methods 63:103-112.
25. Span, A. H., W. Mullers, A. M. Miltenburg, and C. A. Bruggeman. 1991. Cytomegalovirus induced PMN adherence in relation to an ELAM-1 antigen present on infected endothelial cell monolayers. Immunology 72:355-360.
26. Span, A. H., M. C. van Dam Mieras, W. Mullers, J. Endert, A. D. Muller, and C. A. Bruggeman. 1991. The effect of virus infection on the adherence of leukocytes or platelets to endothelial cells. Eur. J. Clin. Investig. 21:331-338.
27. Takahashi, H., and L. A. Harker. 1983. Measurement of human endothelial cells in whole blood. Thromb. Res. 31:1-12.
28. van Dam Mieras, M. C., A. D. Muller, V. W. van Hinsbergh, W. J. Mullers, P. H. Bomans, and C. A. Bruggeman. 1992. The procoagulant response of cytomegalovirus infected endothelial cells. Thromb. Haemostasis 68:364-370.
29. van der Bij, W., R. Torensma, W. J. van Son, J. Anema, J. Schirm, A. M. C. Tegzess, and T. H. The. 1988. Rapid immunodiagnosis of active cytomegalovirus infection by monoclonal antibody staining of blood leucocytes. J. Med. Virol. 25:179-188.
30. van Son, W. J., and T. H. The. 1989. Cytomegalovirus infection after organ transplantation: an update with special emphasis on renal transplantation. Transplant. Int. 2:147-164.
31. van Son, W. J., R. Peset, J. C. Duipmans, T. M. van der Mark, T. H. The, and A. M. Tegzess. 1987. Cytomegalovirus infection after renal transplantation: pulmonary dysfunction measured by decreased diffusing capacity for carbon monoxide in patients with symptomatic and asymptomatic infection. Transplantation 44:149-150.